Company Filing History:
2 out of 1,001 
2 out of 1,866 
Years Active: 2025
Title: **Elizabeth Sharlow: Innovator in Cancer Treatment**
Introduction
Elizabeth Sharlow is a distinguished inventor based in Butler, Pennsylvania. With a total of two patents to her name, she has made significant contributions to the field of pharmaceutical innovation, particularly in developing treatments for cancer. Her groundbreaking work highlights her dedication to enhancing the medical landscape through innovative solutions.
Latest Patents
Sharlow's most notable patents include the innovation titled "In-flow photooxygenation of aminothienopyridinones generates novel PTP4A3 phosphatase inhibitors." This disclosure introduces compounds that inhibit protein tyrosine phosphatase, specifically targeting protein tyrosine phosphatase 4 A3 (PTP4A3). The patent further details pharmaceutical compositions and methods of using these compounds, particularly in the treatment of various cancers. This novel approach emphasizes the potential effectiveness of her findings in combating this pervasive disease.
Career Highlights
Throughout her career, Elizabeth Sharlow has engaged in impactful work with esteemed institutions, including the University of Virginia Patent Foundation and the University of Pittsburgh—the Commonwealth System of Higher Education. Her involvement with these research institutions has allowed her to spearhead significant advancements in the field of health sciences and pharmaceuticals.
Collaborations
Sharlow has collaborated with notable professionals, including Peter Wipf and Nikhil Tasker. Their partnership in research and development has contributed to the depth of innovation in her patents, reflecting a collaborative spirit that is essential in advancing scientific research.
Conclusion
As an inventor, Elizabeth Sharlow has made remarkable strides in creating solutions for cancer treatment through her patented innovations. Her commitment to research and collaboration with peers embodies the essence of progress in the field of pharmaceuticals. Elizabeth's work not only enriches the scientific community but also offers hope in the ongoing battle against cancer.